• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

PILMA

Pharmaceutical Industry Labor-Management Association

GET THE LATEST
  • Home
  • Who We Are
    • About PILMA
    • Trustees
    • Partners
    • Mission Statement
  • What We Do
    • Partnership for Life
    • My Tools, Your Health
    • Saving Money, Saving Lives
    • Progress Through Collaboration
    • Continuous Partners
  • News & Resources
    • America’s Best, Saving America
    • Union Jobs Report
    • PILMA News
    • Stories
      • Union Jobs Report
      • Maryland Senator Hollen Tours IBEW Local 26
      • Smart Local 19
    • Resolutions
    • Reports
    • Video Gallery
      • Facility Tours
  • Contact Us

PILMA Chairman Reaffirms Position on Intellectual Property Protections

April 26, 2018

On April 25, 2018, Ironworkers General President and PILMA Chairman Eric Dean sent the following letter to the Chairman and Ranking Member of the Senate Finance and House Ways and Means Committees. The letter reaffirms PILMA’s commitment to strong intellectual property protections both domestically and in agreements with other countries.

View the letter here.

“The Pharmaceutical Industry Labor-Management Association (PILMA), a coalition labor organizations and companies in the biopharmaceutical industry, is committed to the dual goals of fostering innovation of life-saving medicines and creating high-quality union construction jobs.

The biopharmaceutical sector support more than 4.7 million American jobs, including members of the building and construction trades unions. It is one of the few manufacturing industries that still maintains a significant employment footprint domestically. In order to devote time and resources to the long-term development of new treatments and cures through research and development, it is essential that strong protections of intellectual property are in place and enforced.

PILMA has a longstanding position supporting intellectual property protections in the U.S. and throughout the world.  As PILMA has previously stated, we support intellectual property rights to be part of international rules and regulations that drive U.S. economic growth, job opportunities, and exports.

As your Committees and the Administration looks to use U.S. and international laws to enforce bilateral and multilateral agreements, standards, and regulations with countries around the world, we expect high policy and legal standards to be set and enforced. This includes 12 years of data protection for biologics, which is already U.S. law, to be a standard the Administration seeks to apply and enforce with other countries.

Innovation within the biopharmaceutical sector leads to new discoveries that save lives and help this important US industry remain competitive globally. It is essential for the health of all Americans and those around the world and the U.S. jobs the industry provides that this sector is protected with predictable and strong IP protections.”

 

 

 

Filed Under: Archives, News, Recent News

Primary Sidebar

22.3

MILLION

Union hours supported by the pharmaceutical industry

$774

MILLION

in wages

Footer

  • Contact Us
  • Who We Are
    • About PILMA
    • Trustees
    • Partners
    • Mission Statement
  • What We Do
    • Partnership for Life
    • My Tools, Your Health
    • Saving Money, Saving Lives
    • Progress Through Collaboration
    • Continuous Partners
  • News & Resources
    • Union Jobs Reports
    • PILMA News
    • Resolutions
    • Video Gallery
    • Facility Tours

© 2025 PILMA. All Rights Reserved.
Home | Contact Us | Privacy Policy